Schedule 13G ownership disclosure

Rocket Pharmaceuticals Inc

Common Stock · CUSIP: 77313F106

Event date: 2025-04-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Wellington Management Group LLP

    Shares: 7,151,721.00 · Class: 6.7%

  • Wellington Group Holdings LLP

    Shares: 7,151,721.00 · Class: 6.7%

  • Wellington Investment Advisors Holdings LLP

    Shares: 7,151,721.00 · Class: 6.7%

  • Wellington Management Company LLP

    Shares: 7,151,721.00 · Class: 6.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-25-000154
Form type
SCHEDULE 13G/A
Filer
ROCKET PHARMACEUTICALS, INC.
CIK
CIK 1281895
Filed
May 07, 2025
Reporting period
Apr 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub